Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Adcock Ingram Holdings stock

AIP.JO
ZAE000123436

Price

6,562.00 ZAR
Today +/-
+3.20 ZAR
Today %
+0.93 %

Adcock Ingram Holdings stock price

ZAR
%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Adcock Ingram Holdings stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Adcock Ingram Holdings stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Adcock Ingram Holdings stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Adcock Ingram Holdings's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Adcock Ingram Holdings Stock Price History

DateAdcock Ingram Holdings Price
12/19/20246,562.00 ZAR
12/18/20246,501.00 ZAR
12/17/20246,725.00 ZAR
12/13/20246,500.00 ZAR
12/12/20246,699.00 ZAR
12/11/20246,655.00 ZAR
12/10/20246,601.00 ZAR
12/9/20246,608.00 ZAR
12/6/20246,600.00 ZAR
12/5/20246,678.00 ZAR
12/4/20246,850.00 ZAR
12/3/20246,800.00 ZAR
12/2/20246,840.00 ZAR
11/29/20246,876.00 ZAR
11/28/20246,695.00 ZAR
11/27/20246,695.00 ZAR
11/26/20246,755.00 ZAR
11/25/20246,700.00 ZAR
11/22/20246,729.00 ZAR
11/21/20246,780.00 ZAR

Adcock Ingram Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Adcock Ingram Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Adcock Ingram Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Adcock Ingram Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Adcock Ingram Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Adcock Ingram Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Adcock Ingram Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Adcock Ingram Holdings’s growth potential.

Adcock Ingram Holdings Revenue, EBIT and net profit per share

DateAdcock Ingram Holdings RevenueAdcock Ingram Holdings EBITAdcock Ingram Holdings Net Income
2027e11.5 B ZAR1.46 B ZAR1.13 B ZAR
2026e10.89 B ZAR1.36 B ZAR1.01 B ZAR
2025e10.31 B ZAR1.28 B ZAR960.94 M ZAR
20249.64 B ZAR1.18 B ZAR814.01 M ZAR
20239.13 B ZAR1.14 B ZAR898.41 M ZAR
20228.71 B ZAR1.06 B ZAR800.35 M ZAR
20217.78 B ZAR895.37 M ZAR657.46 M ZAR
20207.35 B ZAR929.39 M ZAR676.37 M ZAR
20197.08 B ZAR906.06 M ZAR687.99 M ZAR
20186.38 B ZAR849.94 M ZAR637.94 M ZAR
20175.94 B ZAR724.42 M ZAR553.53 M ZAR
20165.55 B ZAR605.69 M ZAR168.8 M ZAR
20155.16 B ZAR518.03 M ZAR197.93 M ZAR
20143.62 B ZAR-7.1 M ZAR-965.3 M ZAR
20135.45 B ZAR890.8 M ZAR587.8 M ZAR
20124.6 B ZAR868.8 M ZAR705.6 M ZAR
20114.45 B ZAR1.07 B ZAR754.2 M ZAR
20104.44 B ZAR1.2 B ZAR631.5 M ZAR
20094.01 B ZAR1.04 B ZAR782.4 M ZAR
20083.3 B ZAR1 B ZAR653.1 M ZAR
20072.88 B ZAR961.1 M ZAR2.34 B ZAR
20063.83 B ZAR1.24 B ZAR789.1 M ZAR
20053.32 B ZAR1.24 B ZAR769.1 M ZAR

Adcock Ingram Holdings Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B ZAR)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B ZAR)NET INCOME (B ZAR)NET INCOME GROWTH (%)DIV. (ZAR)DIV. GROWTH (%)SHARES (M)DOCUMENTS
200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e
3.323.832.883.34.014.444.454.65.453.625.165.555.946.387.087.357.788.719.139.6410.3110.8911.5
-15.50-24.8514.6221.3610.860.293.2818.40-33.6142.687.507.057.5110.913.795.8511.954.895.616.875.655.64
82.9171.7895.5255.2150.8452.5748.7145.5341.0731.5136.3336.5937.7739.3539.4037.2927.3729.8329.6728.5226.6925.2623.91
0001.822.042.332.172.092.241.141.872.032.242.512.792.742.132.62.712.75000
0.770.792.340.650.780.630.750.710.59-0.970.20.170.550.640.690.680.660.80.90.810.961.011.13
-2.60196.96-72.1319.75-19.3119.49-6.50-16.74-264.40-120.41-14.72229.1715.197.85-1.60-2.8121.7712.25-9.3517.945.3111.67
-----------------------
-----------------------
172.9172.9172.9173.6173.8174.1171169.1168.8168.7168.83166.48166.29166.3166.26169.95165.97164.77163.75154.63000
-----------------------
Details

Keystats

Revenue and Growth

The Adcock Ingram Holdings Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Adcock Ingram Holdings is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B ZAR)RECEIVABLES (B ZAR)OTHER REC. (M ZAR)INVENTORIES (B ZAR)OTHER CURRENT LIAB. (M ZAR)CURRENT ASSETS (B ZAR)TANGIBLE ASSETS (B ZAR)LONG-T. INVEST. (M ZAR)LONG-T. REC. (M ZAR)INTANGIBLE ASSETS (B ZAR)GOODWILL (M ZAR)OTHER NON-CURRENT ASSETS (M ZAR)NON-CURRENT ASSETS (B ZAR)TOTAL ASSETS (B ZAR)LIABILITIESCOMMON STOCK (M ZAR)ADDITIONAL PAID-IN CAPITAL (B ZAR)RETAINED EARNINGS (B ZAR)OTHER EQUITY (M ZAR)UNREAL. GAINS/LOSSES (M ZAR)EQUITY (B ZAR)LIABILITIES (B ZAR)PROVISIONS (M ZAR)OTHER SHORT-TERM LIAB. (M ZAR)SHORT-TERM DEBTS (B ZAR)LONG-TERM DEBT PORTION (M ZAR)SHORT-TERM REC. (B ZAR)LONG-T. LIAB. (B ZAR)DEFERRED TAXES (M ZAR)OTHER LIAB. (B ZAR)LONG-T. LIABILITIES (B ZAR)DEBT (B ZAR)TOTAL CAPITAL (B ZAR)
20052006200720082009201020112012201320142015201620172018201920202021202220232024
                                       
0.240.650.760.410.691.431.10.490.160.250.150.20.590.40.450.320.060.350.090.09
0.70.862.610.690.9410.991.11.41.091.221.321.431.471.61.41.611.631.851.94
041.823.4168.746.695.5131.4193215.2166.3203.59139.9586.4475.81108.09144.49126.34121.07142.36215.79
0.410.50.430.570.580.720.860.961.561.111.211.171.161.571.311.911.872.172.452.54
00024.452.551108.796.565.358.259.08632.7964.2597.2485.9497.0871.6377.5482.1695.54
1.342.063.821.862.313.33.22.843.412.672.843.463.333.623.563.863.744.344.614.89
0.260.30.260.450.60.861.161.561.771.551.491.421.451.521.541.791.721.741.711.64
01.228.6170.2150.213.82.8139.85205282.05356.35399.99455.1507.89546.88492.16530.72674.6676.62
00000137.4137.427.1190.8136.288.1972.139.8432.0727.9842.7333.723.3416.8313.39
0.220.290.220.210.280.330.460.451.110.820.730.260.330.440.430.650.770.960.950.94
254.6315.416.613.729.193.5265.9258.1321.412.612.5812.5818.18181.93176.34283.51283.51283.51283.51176.34
24.2230.9208.612.420243.85.114.5812.098.131.5918.128.676.394.944.3514.125.88
0.761.130.730.861.071.462.032.443.412.742.622.142.242.652.693.323.33.543.653.47
2.13.194.562.713.394.765.245.286.825.415.465.65.566.276.257.187.047.898.268.35
                                       
00017.317.417.416.916.916.816.916.8917.1517.1517.1517.1416.7516.1816.1815.2814.68
0001.191.21.190.770.550.50.510.510.670.670.670.660.510.260.260.270.27
-2.7-1.940.40.421.081.712.312.893.122.212.492.542.83.233.614.014.414.975.115.13
0000-3.3-7.5-3.9-27.4000000000000
00000000000000000000
-2.7-1.940.41.632.32.913.093.423.642.743.023.233.493.914.34.544.685.245.395.41
0.230.240.260.540.320.410.580.631.291.111.321.531.621.831.611.090.911.041.21.16
275.9358.3221.70136.9319.3254.6235.59.56.63.717.7313.558.2861.55779.35692.93757.52795.61960.38
133.2129.240.451.1271.9332.3222.5198.3133.361.979.85196.6884.07132.75167.51293.6317.41357.41388.9369.23
0.031.341.530.0100001.440.320.30.010.010.25000.0100.010
81.2103.3109.9161.1194.4126.8496431.40.55.113.2700.420028.9934.4527.7235.4242.46
0.752.172.150.770.921.191.561.52.881.51.721.751.732.221.832.191.972.192.432.53
0.720.620.420.280.120.450.350.10.0110.510.50.25000.280.250.310.280.24
00046.72493.9101.9139.12181.8575.8773.14118.91102.33153.51125.23133.6147.35161.15
3.332.321.570.010.010.020.010.020.020.020.020.020.020.020.020.010.020.010.010.01
4.052.941.980.30.140.490.450.220.161.050.620.590.340.140.120.450.390.460.440.41
4.85.114.131.061.061.682.011.723.042.552.342.342.072.361.952.642.362.642.872.94
2.13.174.532.693.364.65.15.146.675.295.365.575.566.276.257.187.047.898.268.35
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Adcock Ingram Holdings provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Adcock Ingram Holdings's financial health and stability.

Assets

Adcock Ingram Holdings's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Adcock Ingram Holdings must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Adcock Ingram Holdings after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Adcock Ingram Holdings's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B ZAR)DEPRECIATION (M ZAR)DEFERRED TAXES (M ZAR)CHANGES IN WORKING CAPITAL (M ZAR)NON-CASH ITEM (B ZAR)PAID INTEREST (M ZAR)PAID TAXES (M ZAR)NET CASH FLOW FROM OPERATING ACTIVITIES (M ZAR)CAPITAL EXPENDITURES (M ZAR)CASH FLOW FROM INVESTING ACTIVITIES (B ZAR)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B ZAR)INTEREST INCOME AND EXPENSES (M ZAR)NET DEBT CHANGE (M ZAR)NET CHANGE IN EQUITY (B ZAR)CASH FLOW FROM FINANCING ACTIVITIES (M ZAR)CASH FLOW FROM OTHER FINANCING ACTIVITIES (B ZAR)TOTAL DIVIDENDS PAID (M ZAR)NET CHANGE IN CASH FLOW (B ZAR)FREE CASH FLOW (M ZAR)SHARE-BASED COMPENSATION (M ZAR)
2005200620072008200920102011201220132014201520162017201820192020202120222023
0.931.10.850.981.040.961.120.890-1.020.340.550.720.90.970.930.911.11.21
28445568821011051160157196146150169164195195192198
0000000000000000000
-860-677-472-586-425-460-598-615-28126-306-331-546-814-731-719-893-804-1,003
0.320.160.28-0.020.060.26-0.10.0701.040.20.160.130.140.10.120.120.17-0.02
00018856402922731011038641252038474559
2483353252332423243411962163687176133246274271296231323
412625709443753862526457-28310427522455389505525329657381
-124-111-95-249-239-333-433-524-344-95-79-95-234-223-215-156-259-329-148
-0.04-0.421.97-0.28-0.33-0.47-0.67-0.53-1.17-0.1-0.04-0.090.08-0.54-0.19-0.47-0.25-0.32-0.14
0.09-0.32.07-0.03-0.09-0.14-0.24-0.01-0.8200.0400.32-0.320.02-0.310.010.010.01
0000000000000000000
-2,090-82-102-79-139269254-305-395904-482-19-242-2760-21-28-32-29
0001.210.010.08-0.29-0.04-0.050.0100.030-0.01-0.02-0.16-0.26-0-0.47
-115-1,101-2,760998-128348-180-534-443911-48010-242-282-21-190-343-37-504
1.98-1.02-2.66-0.130-0-0.01-0.010000000-0.01-0.060-0
000000-136-17900000000000
0.26-0.89-0.081.160.30.74-0.33-0.61-1.641.14-0.090.450.29-0.430.29-0.13-0.270.3-0.26
287.3514.2613.6194514.152993.4-67.2-372.7215.3347.62426.68221.37165.51290.48369.7669.41327.55233.67
0000000000000000000

Adcock Ingram Holdings stock margins

The Adcock Ingram Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Adcock Ingram Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Adcock Ingram Holdings.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Adcock Ingram Holdings's sales revenue. A higher gross margin percentage indicates that the Adcock Ingram Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Adcock Ingram Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Adcock Ingram Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Adcock Ingram Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Adcock Ingram Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Adcock Ingram Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Adcock Ingram Holdings Margin History

Adcock Ingram Holdings Gross marginAdcock Ingram Holdings Profit marginAdcock Ingram Holdings EBIT marginAdcock Ingram Holdings Profit margin
2027e28.52 %12.65 %9.82 %
2026e28.52 %12.45 %9.29 %
2025e28.52 %12.4 %9.33 %
202428.52 %12.26 %8.44 %
202329.67 %12.43 %9.84 %
202229.83 %12.23 %9.19 %
202127.37 %11.51 %8.45 %
202037.28 %12.65 %9.21 %
201939.4 %12.8 %9.72 %
201839.35 %13.32 %9.99 %
201737.77 %12.2 %9.32 %
201636.6 %10.92 %3.04 %
201536.33 %10.04 %3.84 %
201431.52 %-0.2 %-26.7 %
201341.08 %16.36 %10.79 %
201245.53 %18.89 %15.34 %
201148.7 %24.06 %16.93 %
201052.58 %27.03 %14.22 %
200950.86 %26.09 %19.53 %
200855.22 %30.43 %19.79 %
200728.52 %33.38 %81.38 %
200628.52 %32.48 %20.6 %
200528.52 %37.44 %23.18 %

Adcock Ingram Holdings Stock Sales Revenue, EBIT, Earnings per Share

The Adcock Ingram Holdings earnings per share therefore indicates how much revenue Adcock Ingram Holdings has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Adcock Ingram Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Adcock Ingram Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Adcock Ingram Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Adcock Ingram Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Adcock Ingram Holdings Revenue, EBIT and net profit per share

DateAdcock Ingram Holdings Sales per ShareAdcock Ingram Holdings EBIT per shareAdcock Ingram Holdings Earnings per Share
2027e71.3 ZAR0 ZAR7 ZAR
2026e67.5 ZAR0 ZAR6.27 ZAR
2025e63.89 ZAR0 ZAR5.96 ZAR
202462.36 ZAR7.64 ZAR5.26 ZAR
202355.77 ZAR6.93 ZAR5.49 ZAR
202252.84 ZAR6.46 ZAR4.86 ZAR
202146.86 ZAR5.39 ZAR3.96 ZAR
202043.23 ZAR5.47 ZAR3.98 ZAR
201942.57 ZAR5.45 ZAR4.14 ZAR
201838.38 ZAR5.11 ZAR3.84 ZAR
201735.7 ZAR4.36 ZAR3.33 ZAR
201633.31 ZAR3.64 ZAR1.01 ZAR
201530.56 ZAR3.07 ZAR1.17 ZAR
201421.43 ZAR-0.04 ZAR-5.72 ZAR
201332.26 ZAR5.28 ZAR3.48 ZAR
201227.2 ZAR5.14 ZAR4.17 ZAR
201126.04 ZAR6.27 ZAR4.41 ZAR
201025.51 ZAR6.89 ZAR3.63 ZAR
200923.04 ZAR6.01 ZAR4.5 ZAR
200819.01 ZAR5.79 ZAR3.76 ZAR
200716.65 ZAR5.56 ZAR13.55 ZAR
200622.16 ZAR7.2 ZAR4.56 ZAR
200519.19 ZAR7.18 ZAR4.45 ZAR

Adcock Ingram Holdings business model

Adcock Ingram Holdings Ltd is a South African pharmaceutical company specialized in the development, manufacturing, and marketing of medicines. The company was founded in 1891 and is headquartered in Johannesburg. Originally a small company, Adcock Ingram Holdings Ltd has built a strong presence in the African and international markets over the years. The company has multiple business divisions, including pharmaceutical products, medical devices, diagnostics, and nutraceuticals. Adcock Ingram Holdings Ltd's business model is based on the commitment to produce high-quality healthcare products to enhance people's lives. The company invests significant resources in research and development to bring innovative products to the market that meet patients' needs. Adcock Ingram Holdings Ltd works closely with medical professionals, doctors, and healthcare specialists to ensure its products meet the highest standards. Adcock Ingram Holdings Ltd is divided into various business divisions, including pharmaceuticals, medical devices, diagnostics, and nutraceuticals. The company offers a wide range of products suitable for a variety of diseases and ailments. From painkillers to vitamin and mineral supplements, and medications for cancer and HIV/AIDS treatment, the company covers a broad spectrum of medical needs. Additionally, Adcock Ingram Holdings Ltd also offers medical devices and diagnostics to aid doctors and healthcare professionals in patient diagnosis and treatment. Some of Adcock Ingram Holdings Ltd's most well-known brands include Panado, Corenza, Citro-Soda, and Compral. These brands are widely recognized and trusted in South Africa and other African countries in the healthcare sector. In recent years, Adcock Ingram Holdings Ltd has also built a strong presence in the international market. The company has successfully expanded into countries such as Australia, New Zealand, and other countries in Europe and Asia. Adcock Ingram Holdings Ltd has brought its products to market by forming partnerships with local companies and distributors. The company has an extensive global presence and a strong reputation as a reliable and trusted supplier of healthcare products. Adcock Ingram Holdings Ltd is committed to sustainability and corporate social responsibility. The company promotes environmentally friendly practices and strives to reduce the environmental impact of its activities. It also supports various non-profit organizations and foundations that work towards improving healthcare in South Africa and other countries. In conclusion, Adcock Ingram Holdings Ltd is a leading pharmaceutical company specialized in the development and marketing of healthcare products. Through its research and development, partnerships, and commitment to sustainability, the company has achieved a strong position in the African and international markets. With its innovative products and high-quality standards, Adcock Ingram Holdings Ltd continues to strive towards improving people's lives. Adcock Ingram Holdings is one of the most popular companies on Eulerpool.com.

Adcock Ingram Holdings SWOT Analysis

Strengths

Adcock Ingram Holdings Ltd possesses several strengths that contribute to its success in the market.

  • Strong market presence and brand reputation
  • Diverse product portfolio with a wide range of pharmaceutical offerings
  • Strong distribution network enabling broad market reach
  • Solid financial position and profitability
  • Experienced management team with industry expertise

Weaknesses

Despite its strengths, Adcock Ingram Holdings Ltd also faces certain weaknesses that need to be addressed.

  • Relatively high debt levels
  • Dependency on a limited number of large customers
  • Challenges in adapting to rapidly changing market trends
  • Limited international expansion compared to competitors
  • Occasional quality control issues

Opportunities

Adcock Ingram Holdings Ltd can leverage certain opportunities to further expand its market presence and profitability.

  • Increased demand for healthcare products due to aging populations
  • Growth potential in emerging markets, especially in Africa
  • Advancements in technology and innovation offering new product development opportunities
  • Partnerships and strategic alliances with other pharmaceutical companies
  • Expanding product portfolio to include generic and over-the-counter medications

Threats

Adcock Ingram Holdings Ltd should be aware of potential threats that may impact its business operations.

  • Intense competition from local and international pharmaceutical companies
  • Stringent regulations and increasing pricing pressures
  • Risk of patent expirations and generic competition
  • Economic fluctuations and currency exchange rate volatility
  • Potential supply chain disruptions
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Adcock Ingram Holdings Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Adcock Ingram Holdings historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Adcock Ingram Holdings shares outstanding

The number of shares was Adcock Ingram Holdings in 2023 — This indicates how many shares 163.754 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Adcock Ingram Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Adcock Ingram Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Adcock Ingram Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Adcock Ingram Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Adcock Ingram Holdings dividend history and estimates

In 2023, Adcock Ingram Holdings paid a dividend amounting to 2.5 ZAR. Dividend means that Adcock Ingram Holdings distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Adcock Ingram Holdings provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Adcock Ingram Holdings’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Adcock Ingram Holdings's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Adcock Ingram Holdings Dividend History

DateAdcock Ingram Holdings Dividend
2027e3.09 ZAR
2026e3.09 ZAR
2025e3.09 ZAR
20242.83 ZAR
20232.5 ZAR
20222.13 ZAR
20211.7 ZAR
20201 ZAR
20192 ZAR
20181.72 ZAR
20171.39 ZAR
20161.04 ZAR
20150.81 ZAR
20132.01 ZAR
20121.92 ZAR
20111.83 ZAR
20101.58 ZAR
20090.7 ZAR

Adcock Ingram Holdings dividend payout ratio

In 2023, Adcock Ingram Holdings had a payout ratio of 37.3%. The payout ratio indicates the percentage of the company's profits that Adcock Ingram Holdings distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Adcock Ingram Holdings represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Adcock Ingram Holdings could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Adcock Ingram Holdings's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Adcock Ingram Holdings Payout Ratio History

DateAdcock Ingram Holdings Payout ratio
2027e40.67 %
2026e39.83 %
2025e40.83 %
202441.35 %
202337.3 %
202243.85 %
202142.92 %
202025.13 %
201948.22 %
201844.91 %
201741.87 %
2016102.97 %
201569.23 %
201437.3 %
201357.76 %
201246.04 %
201141.5 %
201043.53 %
200915.56 %
200837.3 %
200737.3 %
200637.3 %
200537.3 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Adcock Ingram Holdings.

Eulerpool ESG Scorecard© for the Adcock Ingram Holdings stock

Eulerpool World ESG Rating (EESG©)

68/ 100

🌱 Environment

65

👫 Social

99

🏛️ Governance

39

Environment

Scope 1 - Direct Emissions
21,221
Scope 2 - Indirect emissions from purchased energy
53,980
Scope 3 - Indirect emissions within the value chain
53,281
Total CO₂ emissions
75,201
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees51
Percentage of women in management
Percentage of Asian employees
Share of Asian management14
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share53
Percentage of white employees
White Management Share24
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Adcock Ingram Holdings shareholders

%
Name
Stocks
Change
Date
58.97504 % Bidvest Group Ltd95,126,74206/30/2024
8.81604 % Public Investment Corporation (SOC) Limited14,220,266-1,120,0866/30/2024
1.18402 % Allan Gray Proprietary Limited1,909,82806/30/2024
0.81810 % Old Mutual Customised Solutions (Pty) Ltd1,319,59831,6836/30/2024
0.71726 % Investec Wealth and Investment Management Pty Ltd1,156,94488,7956/30/2024
0.58107 % Dimensional Fund Advisors, L.P.937,26008/31/2024
0.56403 % BlackRock Institutional Trust Company, N.A.909,78609/30/2024
0.50842 % ClucasGray (Pty) Ltd820,077820,0773/31/2024
0.35201 % Centaur Asset Management (Pty.) Ltd.567,79406/30/2024
0.31143 % Nest Asset Management502,337-46,3436/30/2024
1
2
3
4
5
...
7

Adcock Ingram Holdings Executives and Management Board

Mr. Andrew Hall

(61)
Adcock Ingram Holdings Chief Executive Officer, Executive Director (since 2007)
Compensation 7.51 M ZAR

Ms. Dorette Neethling

(49)
Adcock Ingram Holdings Chief Financial Officer, Executive Director (since 2007)
Compensation 4.55 M ZAR

Ms. Basadi Letsoalo

(57)
Adcock Ingram Holdings Executive Director - Human Capital and Transformation (since 2008)
Compensation 4.02 M ZAR

Ms. Nompumelelo Madisa

(44)
Adcock Ingram Holdings Non-Executive Chairman of the Board
Compensation 1.22 M ZAR

Ms. Debra Ransby

(50)
Adcock Ingram Holdings Non-Executive Independent Director
Compensation 874,000 ZAR
1
2
3
4
...
5

Most common questions regarding Adcock Ingram Holdings

What values and corporate philosophy does Adcock Ingram Holdings represent?

Adcock Ingram Holdings Ltd represents a strong set of values and a distinct corporate philosophy. The company prioritizes integrity, transparency, and ethical business practices, ensuring the highest standards in everything it does. Adcock Ingram Holdings Ltd values innovation, continuously striving to develop and deliver high-quality healthcare products for the benefit of its customers. With a customer-centric approach, the company aims to provide accessible and affordable healthcare solutions. Adcock Ingram Holdings Ltd strongly believes in fostering sustainable growth and contributing positively to the communities it operates in. Through its commitment to excellence, Adcock Ingram Holdings Ltd has become a trusted name in the pharmaceutical industry.

In which countries and regions is Adcock Ingram Holdings primarily present?

Adcock Ingram Holdings Ltd is primarily present in South Africa.

What significant milestones has the company Adcock Ingram Holdings achieved?

Adcock Ingram Holdings Ltd has achieved significant milestones throughout its history. Some noteworthy achievements include expanding its product portfolio to include a wide range of prescription and over-the-counter pharmaceuticals. The company has also successfully established itself as a key player in the South African healthcare industry, with a strong market presence and a reputation for delivering high-quality products. Adcock Ingram Holdings Ltd's dedication to research and development has led to the introduction of innovative healthcare solutions, further cementing its position as a leader in the market. Overall, the company's commitment to growth and innovation has contributed to its success and continues to drive its future prospects.

What is the history and background of the company Adcock Ingram Holdings?

Adcock Ingram Holdings Ltd is a leading pharmaceutical company based in South Africa. Established in 1891, the company has a rich history in the healthcare industry. Adcock Ingram specializes in the manufacturing, marketing, and distribution of a wide range of pharmaceutical products, over-the-counter medicines, and personal care products. With a strong presence in both local and international markets, Adcock Ingram has become a trusted name in the pharmaceutical sector. The company has a proven track record of innovation, quality, and commitment to improving healthcare. Adcock Ingram Holdings Ltd continues to play a vital role in providing essential healthcare solutions to people worldwide.

Who are the main competitors of Adcock Ingram Holdings in the market?

The main competitors of Adcock Ingram Holdings Ltd in the market are Aspen Pharmacare Holdings Ltd and Cipla Medpro South Africa Ltd.

In which industries is Adcock Ingram Holdings primarily active?

Adcock Ingram Holdings Ltd is primarily active in the pharmaceutical and healthcare industries.

What is the business model of Adcock Ingram Holdings?

The business model of Adcock Ingram Holdings Ltd is focused on the manufacturing, marketing, and distribution of a wide range of healthcare and pharmaceutical products. Adcock Ingram operates within two primary segments: Prescription and Over-the-Counter (OTC) medicines. Through its Prescription portfolio, the company produces innovative prescription drugs for various therapeutic areas, including cardiovascular, respiratory, and central nervous system disorders. Its OTC segment encompasses a diverse range of consumer healthcare products, such as vitamins, supplements, skincare, and pain relief remedies. Adcock Ingram consistently strives to strengthen its market presence, enhance product offerings, and provide accessible healthcare solutions to meet the evolving needs of its customers.

What is the P/E ratio of Adcock Ingram Holdings 2024?

The Adcock Ingram Holdings P/E ratio is 1,246.55.

What is the P/S ratio of Adcock Ingram Holdings 2024?

The Adcock Ingram Holdings P/S ratio is 105.23.

What is the Quality Investing of Adcock Ingram Holdings?

The Quality Investing for Adcock Ingram Holdings is 6/10.

What is the revenue of Adcock Ingram Holdings 2024?

The Adcock Ingram Holdings revenue is 9.64 B ZAR.

How high is the profit of Adcock Ingram Holdings 2024?

The Adcock Ingram Holdings profit is 814.01 M ZAR.

What is the business model of Adcock Ingram Holdings

Adcock Ingram Holdings Ltd is a pharmaceutical company that was founded in South Africa and is now one of the leading manufacturers and marketers of prescription and over-the-counter drugs, medical devices, and diagnostic tests in Africa. The company is divided into several business segments, including Prescription, Over-the-counter (OTC), Critical Care, Hospital, and Animal Health, each focusing on different market segments and customer needs. They offer prescription medications for various therapeutic areas, including cardiovascular diseases, diabetes, oncology, neurology, and psychiatry, as well as specialized products for women and children, generics, and biosimilars. In the OTC segment, they offer a wide range of over-the-counter drugs, including pain relievers, cold remedies, vitamins and minerals, herbal remedies, and skincare products. The Critical Care segment includes medications and medical devices for intensive care and emergency medicine, such as anesthetics, ventilators, infusion solutions, and blood products. In the Hospital segment, they provide products and services to hospitals and medical facilities, including antibiotics, anesthetics, diagnostics, and surgical instruments. The Animal Health segment offers veterinary drugs and products for farm and companion animals, including antibiotics, vaccines, and parasiticides. Adcock Ingram Holdings Ltd distributes its products through various channels, including pharmacies, hospitals, wholesalers, and veterinarians. The company also has subsidiaries in some African countries and exports some products to other countries. They emphasize research and development and have their own innovation center. Additionally, they collaborate closely with other research institutions and universities to develop new therapies and products. Adcock Ingram Holdings Ltd also emphasizes its responsibility to society and the environment and works on various initiatives to promote health, education, and environmental protection. Overall, their business model is focused on a wide range of products, customers, and markets. The company positions itself in the middle of the market, offering both prescription and over-the-counter products. Through research and development and close collaboration with other partners, they strive for continuous innovation. They also emphasize their social responsibility and commitment to sustainable development.

What is the Adcock Ingram Holdings dividend?

Adcock Ingram Holdings pays a dividend of 2.13 ZAR distributed over payouts per year.

How often does Adcock Ingram Holdings pay dividends?

The dividend cannot currently be calculated for Adcock Ingram Holdings or the company does not pay out a dividend.

What is the Adcock Ingram Holdings ISIN?

The ISIN of Adcock Ingram Holdings is ZAE000123436.

What is the Adcock Ingram Holdings ticker?

The ticker of Adcock Ingram Holdings is AIP.JO.

How much dividend does Adcock Ingram Holdings pay?

Over the past 12 months, Adcock Ingram Holdings paid a dividend of 2.83 ZAR . This corresponds to a dividend yield of about 0.04 %. For the coming 12 months, Adcock Ingram Holdings is expected to pay a dividend of 3.09 ZAR.

What is the dividend yield of Adcock Ingram Holdings?

The current dividend yield of Adcock Ingram Holdings is 0.04 %.

When does Adcock Ingram Holdings pay dividends?

Adcock Ingram Holdings pays a quarterly dividend. This is distributed in the months of October, April, October, October.

How secure is the dividend of Adcock Ingram Holdings?

Adcock Ingram Holdings paid dividends every year for the past 13 years.

What is the dividend of Adcock Ingram Holdings?

For the upcoming 12 months, dividends amounting to 3.09 ZAR are expected. This corresponds to a dividend yield of 0.05 %.

In which sector is Adcock Ingram Holdings located?

Adcock Ingram Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Adcock Ingram Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Adcock Ingram Holdings from 9/23/2024 amounting to 0.08 ZAR, you needed to have the stock in your portfolio before the ex-date on 9/20/2024.

When did Adcock Ingram Holdings pay the last dividend?

The last dividend was paid out on 9/23/2024.

What was the dividend of Adcock Ingram Holdings in the year 2023?

In the year 2023, Adcock Ingram Holdings distributed 2.5 ZAR as dividends.

In which currency does Adcock Ingram Holdings pay out the dividend?

The dividends of Adcock Ingram Holdings are distributed in ZAR.

All fundamentals about Adcock Ingram Holdings

Our stock analysis for Adcock Ingram Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Adcock Ingram Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.